Table I.
Characteristics of all cases of epidemic pediatric Kaposi sarcoma identified at the Uganda Cancer Institute, Kampala, Uganda over a 32 month period between 2004 and 2007
| Total | Malesa | Females | |
|---|---|---|---|
| KS cases, n (percent) | 73 (100%) | 37 (50.7%) | 36 (49.3%) |
| Age in years, median (range), n=56 | 10.1 (2 – 18) | 9.3 (2 – 16) | 11.0 (2 – 18) |
| CD4 T-cells/uL, median (IQR) n=36 | 210 (21 – 482) | 165 (16 – 538) | 263 (26 – 464) |
| CD4%, median (IQR) n=35 | 7.4 (1.2 – 13.5) | 8.2 (1.9 – 11.1) | 6.7 (1.2 – 14.7) |
| Location of lesions n=42b | |||
| Skin involvement | 20 (47.6%) | 10 (45.5%) | 10 (50.0%) |
| Oral cavity involvement | 9 (21.4%) | 4 (20.0%) | 5 (22.7%) |
| Viscera involvement | 5 (11.9%) | 3 (15.0%) | 2 (9.1%) |
| Lymph node involvement | 25 (59.5%) | 11 (55.0%) | 14 (58.3%) |
a
No statistically significant differences were observed between males and females for the characteristics listed.
b
Categories of lesion location not mutually exclusive.